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Refeeding syndrome (RFS) describes the biochemical changes, clinical manifestations, and complications that can occur as a
consequence of feeding a malnourished catabolic individual. RFS has been recognised in the literature for over ﬁfty years and
can result in serious harm and death. Crude estimates of incidence, morbidity, and mortality are available for speciﬁc populations.
RFS can occur in any individual but more commonly occurs in at-risk populations. Increased awareness amongst healthcare
professionals is likely to reduce morbidity and mortality. This review examines the physiology of RFS and describes the clinical
manifestations. A management strategy is described. The importance of a multidisciplinary approach is emphasized.
1.Introduction
RFS is well recognised. It occurs after the reintroduction
of feeding after a period of starvation or fasting [1]. RFS
describes a series of metabolic and biochemical changes that
occur as a consequence of reintroduction of feeding after a
period of starvation or fasting. This unfavorable metabolic
response causes nonimmune-mediated harm to the body
and can be mild, moderate, or severe. Although, the physiol-
ogy and pathophysiology are well known, the circumstances
under which RFS occurs, the clinical manifestations, and the
management of these patients are less clear [2, 3].
1.1. Methods. A PubMed search for the terms “refeeding
syndrome” AND “hypophosphataemia” generated two hun-
dred and seven separate articles. There were no randomized
controlled trials identiﬁed.
1.2. Physiology. With food in abundance, carbohydrates
provide for most of our energy requirements. Glucose,
the principal product of carbohydrate digestion, is actively
cotransported along with sodium at the intestinal brush
border against a concentration gradient. Glucose enters
the portal circulation by facilitated diﬀusion and blood
sugar levels rise. This stimulates the release of the peptide
hormone insulin from pancreatic islet cells. Insulin secretion
has several eﬀects. It promotes glucose uptake and storage
(glycogenesis), inhibits the breakdown of fats (lipolysis), and
increases cellular uptake of potassium. When glycogen stor-
agecapacityisexceeded,lipogenesisoccurswithnonoxidised
glucose being converted to fat and stored as triglycerides
in adipose tissue. Together, the consequence is for blood
glucose levels to fall with a concomitant reduction in insulin
secretion [4].
With starvation, levels of glucose begin to fall within
24 to 72 hours. This results in the release of the peptide
hormone glucagon and a reduction in insulin secretion
[10]. Glucose levels are maintained by glycogenolysis but
glycogen stores rarely last more than 72 hours [11]. Glucose
homeostasisisessentialbecausecertaintissues,suchasbrain,
erythrocytes, and cells of the renal medulla are obligate
glucose users [12] .T h e s ed e m a n d sf o rg l u c o s ea r em e tb y
the process of gluconeogenesis by which noncarbohydrate
sources are metabolized to glucose. The most important of
these is the muscle protein alanine. In addition, fatty acid
oxidation in liver hepatocytes generates ketone bodies. These
are converted to acetyl-coenzyme-A generating energy via
the Kreb’s cycle. Further energy production from lactate and
pyruvate (the products of glycolysis) and amino acids occurs
via the Cori cycle [4]. In summary, metabolic adaptation
occurs to ensure survival on fat fuel economy [13]. There is
a resultant loss of body fat and protein and an accompanying
depletion of potassium, phosphate, and magnesium [14, 15].2 Gastroenterology Research and Practice
Table 1: Clinical manifestations of electrolyte abnormalities associated with refeeding syndrome [1, 5–9].
Clinical Manifestation
Phosphate (PO4
2−)
Hypophosphataemia (normal range 0.8–1.45mmol/l) presents as
Cardiovascular: heart failure, arrhythmia, hypotension, cardiomyopathy shock, death
Renal: acute tubular necrosis, metabolic acidosis
Skeleton: rhabdomyolysis, weakness, myalgia, diaphragm weakness
Neurology: delirium, coma, seizures, tetany
Endocrine: hyperglycemia, insulin resistance, osteomalacia
Haematology: haemolysis, thrombocytopenia, leukocyte dysfunction
Potassium (K
+)
Hypokalemia (normal range 3.5–5.1mmol/l) presents as
Cardiovascular: hypotension, ventricular arrhythmias, cardiac arrest, bradycardia or
tachycardia
Respiratory: hypoventilation, respiratory distress, respiratory failure
Skeleton: weakness, fatigue, muscle twitching
Gastrointestinal: diarrhoea, nausea, vomiting, anorexia, paralytic ileus, constipation
Metabolic: metabolic alkalosis
Magnesium (Mg
2+)
Hypomagnesaemia (normal range 0.77–1.33mmol/l) presents as
Cardiovascular: paroxysmal atrial or ventricular arrhythmias, repolarisation alternans
Respiratory: hypoventilation, respiratory distress, respiratory failure
Neuromuscular: weakness, fatigue, muscle cramps (Trousseau and Chvostek) weakness,
ataxia, vertigo, paresthesia, hallucinations, depression, convulsions
Gastrointestinal: abdominal pain, diarrhoea, vomiting, loss of appetite, and constipation
Other: anaemia, hypocalcemia
NB: many cases of hypomagnesaemia do not manifest clinically till very late
Sodium (Na
+)
Hyponatremia (normal range 136–145mmol/l) ensues during RFS due to hyperglycaemia and
presents as:
Cardiovascular: heart failure and arrhythmia
Respiratory: respiratory failure, pulmonary oedema.
Renal: renal failure
Skeleton: muscle cramps, fatigue, ﬂuid retention and swelling (oedema)
Vitamins
Deﬁciency of thiamine (especially in alcoholism) presents as
Neurology: Wernicke-Korsakoﬀ syndrome, Karsakoﬀ’s psychosis,
Cardiovascular: congestive heart failure and lactic acidosis, beriberi, disease
Skeleton: muscle weakness
Homeostatic mechanisms maintain serum concentrations of
these ions at the expense of intracellular stores. Serum levels
mayremainnormaldespiteamarked reductionin totalbody
levels.
The reintroduction of nutrition to a starved or fasted
individual results in a rapid decline in both gluconeogeneis
and anaerobic metabolisms [13]. This is mediated by the
rapidincreaseinseruminsulinthatoccursonrefeeding[10].
Insulin stimulates the movement of extracellular potassium,
phosphate, and magnesium to the intracellular compart-
ment. Depleted intracellular stores and a large concentration
gradient ensure a rapid fall in the extracellular concentration
of these ions [16, 17]. Osmotic neutrality must be main-
tained resulting in the retention of sodium and water [18].
Reactivation of carbohydrate-dependent metabolic pathways
increases demand for thiamine, a cofactor required for
cellular enzymatic reactions [19, 20]. The deﬁciencies of
phosphate, magnesium, potassium, and thiamine occur to
varyingdegreesandhavediﬀerenteﬀectsindiﬀerentpatients
[5]. Some, such as chronic alcohol abusers or those with
long-term starvation, are more vulnerable to the metabolic
consequences of mineral or elemental deﬁciencies [21–28].
This explains why RFS is not deﬁned by a clear set of signs
and symptoms but is considered an arbitrary term referring
to a wide spectrum of biochemical abnormalities and clinical
consequences [5]( Table 2).
1.3. What Is Refeeding Syndrome? First reports of the
syndrome appeared in the 1950s after observations of
malnourished prisoners of war who developed cardiac and
neurological symptoms soon after the recommencement of
feeding[31,32].Thereisnointernationallyagreeddeﬁnition
of RFS [6]. In 2001 Crook et al. referred to a syndrome of
severe electrolyte and ﬂuid shifts associated with metabolic
abnormalities in malnourished patients undergoing refeed-
ing, whether orally, enterally, or parenterally [1].Gastroenterology Research and Practice 3
Table 2: Malnourished patients at risk of RFS [5, 6, 8, 29].
Anorexia nervosa Chronic alcoholism
Radiation therapy Major stressors without food
for >7d a y s
Oncology patients Postoperative patients
Severe malnutrition
(Marasmus/Kwashiorkor) Institutionalized patients
Pathological weight loss Hunger strikes
Stroke (Neurological problems) Malabsorption diseases
Inﬂammatory bowel diseases Post bariatric surgery
Chronic pancreatitis Elderly, poor social
circumstance
Acquired Immunodeﬁciency
Syndrome Diabetes Mellitus
Table 3: Monitoring patients at risk of developing RFS [5, 6, 8, 30].
Clinical monitoring Biochemical monitoring
Early identiﬁcation of high
risk patients
Monitor biochemistry and
electrolyte levels
Monitor blood pressure
and pulse rate Monitor blood glucose levels
Monitor feeding rate ECG monitoring in severe cases
Meticulously document
ﬂuid intake and output Account other sources of energy
Monitor change in body
weight
(dextrose, propofol,
medications)
Monitor for neurologic
signs and symptoms
Patient education
As there is nostrict deﬁnition, it is not surprising thatthe
incidence of RFS is unclear. Robust epidemiological studies
are lacking in part due to the absence of accepted diagnostic
criteriaorinternationallyagreedguidelinesfordetectingRFS
[5]. Most published data from prospective and retrospective
case series do not reﬂect overall incidence.
Hypophosphataemia is the adopted surrogate marker
for diagnosing RFS though low serum phosphate is not
pathognomonic [33]. Estimates of hypophosphataemia in
those at risk of RFS are high [2, 7, 34]. In a prospective
study of sixty-two patients in the intensive care unit refed
after being starved for 48 hours, twenty-one patients (34%)
experienced refeeding hypophosphataemia. There was an
association with low prealbumin concentration [7]. In
a separate study of one hundred and six patients with
histologically conﬁrmed cancer, the incidence was 25%
[34]. Hypophosphataemia is uncommon in the hospitalized
patient population, occurring in 2% of all requests received
for serum phosphate determination in one institution over
an eighteen-month period [33]. There are limitations to
relying on low serum phosphate and levels may be normal
in patients with multiorgan failure or in the presence of
impaired renal function.
An alternative to the lack of reliable RFS incidence
data is to examine the prevalence of those at risk of
RFS. A consensus exists in the literature that prevention is
preferable to treating established RFS. Therefore, estimating
the prevalence of those at risk might assist in understanding
the potential scale of RFS. The predominant risk factor for
RFS is malnutrition. The report of the British Association of
Parenteral and Enteral Nutrition (BAPEN, 2008) estimated
in the UK that there were more than three million people
whoareeithermalnourishedoratriskofmalnutritionwhilst
the British Dietetic Association estimated a 20% to 60% risk
of malnutrition in patients being admitted to hospital. In
2005 Hise et al. estimated that 30% to 50% of hospitalized
patientsaremalnourished[35].Morleyin2002estimatedthe
prevalence of malnutrition is 1% to 15% in patients attend-
ing outpatient, 25% to 60% in the institutionalized patients,
anditis35%to65%inhospitalizedpatients[36].Ahospital-
based study screened 32,837 patients ﬁnding nearly one ﬁfth
were severely undernourished or at risk for undernutrition
andthattheriskwasdirectlyrelatedtoage[37].Malnutrition
is a problem in many diﬀerent disease groups, including
cancer (5–80%), neurology (4–66%), elderly (0–85%), sur-
gical/critical illness (0–100%), respiratory disease (5–60%),
gastrointestinal and liver disease (3–100%), HIV/AIDS (8–
98%), and renal disease (10–72%) [30]( Table 2). These data
underscore the signiﬁcant possibility for RFS and highlight
the link between comorbidity, nutritional status, and RFS.
2. ClinicalManifestations
Symptoms of RFS are variable, unpredictable, may occur
without warning, and may occur late. Symptoms occur
because changes in serum electrolytes aﬀect the cell mem-
brane potential impairing function in nerve, cardiac, and
skeletal muscle cells. The variable clinical picture in RFS
reﬂects the type and severity of biochemical abnormality
present. With mild derangements in these electrolytes, there
may be no symptoms. More often, the spectrum of presen-
tation ranges from simple nausea, vomiting, and lethargy
to respiratory insuﬃciency, cardiac failure, hypotension,
arrhythmias, delirium, coma, and death. Clinical deteriora-
tion may occur rapidly if the cause is not established and
appropriate measures not instituted. Low serum albumin
concentration may be an important predictor for hypophos-
phataemia [7] although albumin is not a nutritional marker.
The biochemical abnormalities and associated symptoms
seen in RFS are summarized (Table 1).
3. Management
The principles of management are to correct biochemical
abnormalities and ﬂuid imbalances returning levels to nor-
mal where possible. The optimum timing for correcting
abnormalities in established RFS has been the source of
controversy. The view that correction of electrolyte abnor-
malities must occur before commencement of feeding [1]
has been revised and recent National Institute of Health
and Clinical Excellence in the United Kingdom guidelines4 Gastroenterology Research and Practice
Table 4: Refeeding regime for patients at risk of RFS [5, 29].
Day Calorie intake (All feeding routes) Supplements
Day 1
10kcal/kg/day
For extreme cases
(BMI < 14kg/m2 or no food >15 days)
5kcal/kg/day
Carbohydrate: 50–60%
Fat: 30–40%
Protein: 15–20%
Prophylactic supplement
PO4
2−: 0.5–0.8mmol/kg/day
K
+: 1–3mmol/kg/day
Mg
2+: 0.3-0.4mmmol/kg/day
Na
+: <1mmol/kg/day (restricted)
IV ﬂuids-Restricted, maintain “zero” balance
IV Thiamine + vitamin B complex 30 minutes prior to feeding
Day 2–4
Increase by 5kcal/kg/day
If low or no tolerance stop or keep
minimal feeding regime
Check all biochemistry and correct any abnormality
Thiamine + vitamin B complex orally or IV till day 3
Monitoring as required (Table 3)
Day 5–7 20–30kcal/kg/day
Check electrolytes, renal and liver functions and minerals
Fluid: maintain zero balance
Consider iron supplement from day 7
Day 8–10 30kcal/kg/day or increase to full requirement Monitor as required (Table 3)
If RFS is suspected based on clinical and biochemical assessment or the patient develops intolerance to artiﬁcial nutritional support, the energetic intake
should be reduced or stopped.
Feeding rate should be increased to meet full requirements for ﬂuid, electrolytes, vitamins, and minerals if the patient is clinically and biochemically stable.
[29] indicate that feeding and correction of biochemical
abnormalities can occur in tandem without deleterious
eﬀects to the patient [5, 8]. No published randomised trial
data is available to support either view.
Prevention is the key to successful management [38].
Three factors appear fundamental: early identiﬁcation of
at risk individuals, monitoring during refeeding (Table 3),
and an appropriate feeding regimen. Anticipating the risk of
developing RFS prevents complications before they develop.
This is aided by taking a detailed history, through clinical
examination and by identifying high-risk patients with early
involvement of the nutrition support team [39, 40]. Patients
should be screened for risk of developing RFS on admission
to hospital or when being assessed in the community. Those
identiﬁed as being either malnourished or at high risk
of not being able to meet their nutritional requirements
should be appropriately referred for a formal nutritional
assessment. Qualiﬁed dieticians or specialist nutrition nurses
are required to perform nutritional assessments leading to
the formulation of individualized strategies for the patient
[16]. Eﬀective communication within and between teams
is a pre-requisite to achieve best care. The successful man-
agement of patients requires a multidisciplinary approach
including nutritionists, nurses, and doctors meeting reg-
ularly to discuss changing nutritional needs of patients
[39, 41–43].
4. FeedingRegimen inRFS
There are numerous published regimens for feeding patients
at risk of RFS. None are evidence based. Irrespective of
which particular feeding regimen is employed, the common
denominator must be to follow the principles of permissive
underfeeding. We recommend a regime (Table 4)b a s e do n
current guidelines, published literature, and expert opinion
[5, 29, 44, 45].
5. Summary
All clinicians caring for vulnerable groups who might
require nutritional support should recognize the risk of RFS.
The lack of randomized controlled trials in this area of
medicine means that management is based on anecdotal
data rather than evidence. This emphasizes the importance
of minimizing risks of RFS by cautious reintroduction of
feeding. We recommend that all patients receiving artiﬁcial
nutritional support are entered into a database that can be
regularly audited and evaluated to ensure best practice and
adherence to current guidelines.
It is important to emphasize that RFS does not represent
asingularconditionorsyndromeratheritdescribesanillness
spectrum that occurs under particular circumstances within
high-risk populations. Improved understanding of energetic
requirements in healthy and sick patients will help improve
understanding and allow for developing novel strategies to
minimize risk of RFS to patients.
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